A CLIA-certified germline genetic assay that identifies an elevated risk for hereditary cancers and uncovers actionable findings.
Thorough sequencing of the 25 most relevant genes for common hereditary cancers.
Identifies an elevated risk for 7 hereditary cancers, including but not limited to breast, ovarian, prostate, pancreatic, colorectal, renal, and gastric cancer.
Clinical results that may be used to guide the approach to health and prevention.
PredicineHEREDITARY is a CLIA-certified test.
If you have any questions or need assistance, complete this form and one of our dedicated team members will be in touch soon.